Q&A With Joao Lima From Johns Hopkins Hospital: Managing Hypertension Through Medication and Lifestyle Changes Help Patients Move Forward
PCSK9 inhibitors have been the focus of the cardiology community and with the approval of two medications in the past few months these drugs could soon make their way to a large number of patients needing help managing their cholesterol levels using more than just statins.
Congestive heart failure is a serious condition facing people around the world. Early trials of a gene therapy have showed promise to not only help these patients with the condition but also make their hearts healthier.
Just because researchers go into a study with a hypothesis they hope to prove, it does not mean the results will be what they were hoping for.
Researchers from the University of Washington in Seattle reported that the use of avatars (digital representations of a coach, buddy, or teacher) improved user satisfaction in interactive, online weight management programs for obese teens.
Cardiovascular patients are the focus of the recent drug approval by the Food and Drug Administration (FDA). Branded under the name Durlaza, the 24-hour extended-release aspirin is the first of its kind and is expected to become available before the end of the year.
A general practitioner can gain a better understanding of a patient’s underlying cardiac ailments by focusing on the fundamentals of pacemakers and automated implantable cardioverter defibrillators (AICDs).In the first part of this 3-part article (“Pacemakers and AICDs: The ABCs”), we discussed distinguishing between pacemakers and AICDs. The second part (“Pacemakers and AICDs: Nomenclature and Malfunction”) addressed pacemaker nomenclature and device function, malfunction, and pseudomalfunction. Here we cover interrogation reports and interpretation of EKGs.
Several large groups combined data to look at results of a study on heart failure patients to see whether age and gender affected treatment options prescribed by patients.
Treating one patient for an illness can answer some questions for doctors. However, in many cases looking at the larger patient population can answer not only why the patients got sick, but what can be done to keep them healthy in the long run.
New research suggests that cold weather may be an underappreciated hazard for patients with atrial fibrillation.
In the time since Florence Nightingale first developed the profession of nursing as it is known today a lot has changed for the men and women in the field. Even still the work they do has been a key part of the medical world as training has increased and improved as well.
The glucose-lowering medication lixisenatide was found not neither increase nor decrease cardiovascular (CV) events compared with placebo in patients afflicted with type 2 diabetes and acute coronary syndrome.
There could be a new first-line treatment for hypertension in patients needing diuretic therapy, according to research presented at the European Society of Cardiology (ESC) Congress conference in London, UK.
It was less than two decades ago that researchers uncovered the role of PCSK9 in a person's body. In just the past few months two new medications have been developed that could go a long way in helping win the fight against bad cholesterol.
A review of men in Finland showed varying amount of time in the sauna showed benefits in preventing heart disease.
A 47 year old woman with no past medical history presented with back pain a month prior, and an MRI of the lumbar spine was performed and demonstrated a mass protruding into S1 concerning for hemangioma.
It may be cool to sip on a Coca-Cola that features your name right on the product, but a report that's been making the rounds details the metabolic roller coaster ride that drinking even a single can unleashes on the body.
At least 5 studies indicating that testosterone replacement therapy either has no effect on cardiovascular health -- or tends to improve it -- appeared during the 3-week period immediately after the US Food and Drug Administration's controversial decision to mandate warnings about the potential cardiovascular risks of such treatment.
Heart failure may be one of the most common conditions a cardiologist sees on a daily basis but there are also many misconceptions about its treatment and diagnosis. Whether on the football field or running an endurance race there are also other issues doctors are working to address across the scope of the cardiology field.
The US Food and Drug Administration has warned physicians that it may be dangerous to use a device known as the Lariat to close the left atrial appendage in patients with heart arrhythmias.
What factors must be considered to ensure optimal management of perioperative cardiac arrest in the cardiac surgery patient?
There are difficult patients, and ideal patients. A cardiologist offers advice on relating to them all.
A 36-year-old man presents to his primary care physician's office for follow-up after being told he had an abnormal ECG at a health fair he attended. He has no complaints. He is sedentary and does not participate in any exercise or athletic activity.
Dr. Arruda is a hematology researcher at The Children's Hospital of Philadelphia and an associate professor of Pediatrics in the Perelman School of Medicine at the University of Pennsylvania. His laboratory focuses on gene-based strategies for the treatment of bleeding and thrombotic diseases.
There is consistent observational data that identifies concomitant use of proton pump inhibitors for gastroesophageal reflux disease and clopidogrel following acute coronary syndrome increases the risk of recurrent cardiovascular events. While a variety of theories exist (lower pH alters absorption, etc.), no clear factor has been identified.
This study was a meta-analysis that examined the association between sedentary behavior and hospitalizations, all-cause mortality, cardiovascular disease, diabetes and cancer in adults.
